Neuroendocrine Gastroenteropancreatic Tumours: ESMO Clinical Practice Guidelines

Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii124-vii130.
Authors: K. Öberg, U. Knigge, D. Kwekkeboom, A. Perren

Neuroendocrine gastroenteropancreatic tumors (GEP-NETs) constitute a heterogeneous group of tumors with their origin in neuroendocrine cells of the embryological gut. This guideline focuses on diagnosis and pathology/molecular biology, staging and risk assessment, management of local/locoregional disease, management of advances/metastatic disease, medical therapy, systemic chemotherapy, peptide receptor-targeted radiotherapy, and response evaluation and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings